Literature DB >> 23459514

A mini-intronic plasmid (MIP): a novel robust transgene expression vector in vivo and in vitro.

Jiamiao Lu1, Feijie Zhang, Mark A Kay.   

Abstract

The bacterial backbone (BB) sequences contained within a canonical plasmid DNA dampen exogenous transgene expression by tenfold to 1,000-fold over a period of a few weeks following transfection into quiescent tissues such as the liver. Minicircle DNA vectors devoid of bacterial plasmid backbone sequences overcome transgene silencing providing persistent transgene expression. Because, we recently established that the length rather than sequence of the DNA flanking the transgene expression cassette is the major parameter affecting transgene silencing, we developed an alternative plasmid propagation process in which the essential bacterial elements for plasmid replication and selection are placed within an engineered intron contained within the eukaryotic expression cassette. As with the minicircle vector, the mini-intronic plasmid (MIP) vector system overcomes transgene silencing observed with plasmids but in addition provides between 2 and often 10 times or higher levels of transgene expression compared with minicircle vectors containing the same expression cassette in vivo and in vitro. These improved plasmids will benefit all studies involving gene transfer/therapy approaches.

Mesh:

Substances:

Year:  2013        PMID: 23459514      PMCID: PMC3666631          DOI: 10.1038/mt.2013.33

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  32 in total

1.  Site specific recA--independent recombination between bacterial plasmids: involvement of palindromes at the recombinational loci.

Authors:  D J Kopecko; S N Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  1975-04       Impact factor: 11.205

2.  Cell genetics and hereditary symbiosis.

Authors:  J LEDERBERG
Journal:  Physiol Rev       Date:  1952-10       Impact factor: 37.312

3.  Dynamic gene expression after systemic delivery of plasmid DNA as determined by in vivo bioluminescence imaging.

Authors:  Andrew Wilber; Joel L Frandsen; Kirk J Wangensteen; Stephen C Ekker; Xin Wang; R Scott McIvor
Journal:  Hum Gene Ther       Date:  2005-11       Impact factor: 5.695

4.  Improved production and purification of minicircle DNA vector free of plasmid bacterial sequences and capable of persistent transgene expression in vivo.

Authors:  Zhi-Ying Chen; Cheng-Yi He; Mark A Kay
Journal:  Hum Gene Ther       Date:  2005-01       Impact factor: 5.695

5.  A new DNA vehicle for nonviral gene delivery: supercoiled minicircle.

Authors:  A M Darquet; B Cameron; P Wils; D Scherman; J Crouzet
Journal:  Gene Ther       Date:  1997-12       Impact factor: 5.250

6.  G triplets located throughout a class of small vertebrate introns enforce intron borders and regulate splice site selection.

Authors:  A J McCullough; S M Berget
Journal:  Mol Cell Biol       Date:  1997-08       Impact factor: 4.272

7.  Functional analysis of the polypyrimidine tract in pre-mRNA splicing.

Authors:  C J Coolidge; R J Seely; J G Patton
Journal:  Nucleic Acids Res       Date:  1997-02-15       Impact factor: 16.971

8.  Introns increase transcriptional efficiency in transgenic mice.

Authors:  R L Brinster; J M Allen; R R Behringer; R E Gelinas; R D Palmiter
Journal:  Proc Natl Acad Sci U S A       Date:  1988-02       Impact factor: 11.205

9.  Heterologous introns can enhance expression of transgenes in mice.

Authors:  R D Palmiter; E P Sandgren; M R Avarbock; D D Allen; R L Brinster
Journal:  Proc Natl Acad Sci U S A       Date:  1991-01-15       Impact factor: 11.205

10.  Expression enhancement of a rice polyubiquitin gene promoter.

Authors:  Elumalai Sivamani; Rongda Qu
Journal:  Plant Mol Biol       Date:  2006-01       Impact factor: 4.335

View more
  26 in total

Review 1.  Overcoming Gene-Delivery Hurdles: Physiological Considerations for Nonviral Vectors.

Authors:  Andrew B Hill; Mingfu Chen; Chih-Kuang Chen; Blaine A Pfeifer; Charles H Jones
Journal:  Trends Biotechnol       Date:  2015-12-23       Impact factor: 19.536

2.  Advanced Design of Dumbbell-shaped Genetic Minimal Vectors Improves Non-coding and Coding RNA Expression.

Authors:  Xiaoou Jiang; Han Yu; Cui Rong Teo; Genim Siu Xian Tan; Sok Chin Goh; Parasvi Patel; Yiqiang Kevin Chua; Nasirah Banu Sahul Hameed; Antonio Bertoletti; Volker Patzel
Journal:  Mol Ther       Date:  2016-06-30       Impact factor: 11.454

3.  Biomaterials at the interface of nano- and micro-scale vector-cellular interactions in genetic vaccine design.

Authors:  Charles H Jones; Anders P Hakansson; Blaine A Pfeifer
Journal:  J Mater Chem B       Date:  2014-09-12       Impact factor: 6.331

4.  Sequence-Modified Antibiotic Resistance Genes Provide Sustained Plasmid-Mediated Transgene Expression in Mammals.

Authors:  Jiamiao Lu; Feijie Zhang; Andrew Z Fire; Mark A Kay
Journal:  Mol Ther       Date:  2017-03-30       Impact factor: 11.454

Review 5.  DNA vaccines for prostate cancer.

Authors:  Christopher D Zahm; Viswa Teja Colluru; Douglas G McNeel
Journal:  Pharmacol Ther       Date:  2017-02-07       Impact factor: 12.310

Review 6.  Cardiac gene therapy: are we there yet?

Authors:  P N Matkar; H Leong-Poi; K K Singh
Journal:  Gene Ther       Date:  2016-04-29       Impact factor: 5.250

7.  Mini-intronic plasmid vaccination elicits tolerant LAG3+ CD8+ T cells and inferior antitumor responses.

Authors:  Viswa Teja Colluru; Christopher D Zahm; Douglas G McNeel
Journal:  Oncoimmunology       Date:  2016-09-02       Impact factor: 8.110

8.  A 5' Noncoding Exon Containing Engineered Intron Enhances Transgene Expression from Recombinant AAV Vectors in vivo.

Authors:  Jiamiao Lu; James A Williams; Jeremy Luke; Feijie Zhang; Kirk Chu; Mark A Kay
Journal:  Hum Gene Ther       Date:  2017-01       Impact factor: 5.695

Review 9.  State-of-the-art human gene therapy: part I. Gene delivery technologies.

Authors:  Dan Wang; Guangping Gao
Journal:  Discov Med       Date:  2014 Jul-Aug       Impact factor: 2.970

10.  Overcoming nonviral gene delivery barriers: perspective and future.

Authors:  Charles H Jones; Chih-Kuang Chen; Anitha Ravikrishnan; Snehal Rane; Blaine A Pfeifer
Journal:  Mol Pharm       Date:  2013-10-16       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.